Article Text

Download PDFPDF
Asporin repeat polymorphism in rheumatoid arthritis
  1. B Torres1,*,
  2. G Orozco2,*,
  3. J R García-Lozano1,
  4. J Oliver2,
  5. O Fernández1,
  6. M A González-Gay3,
  7. A Balsa4,
  8. A García5,
  9. D Pascual-Salcedo6,
  10. M A López-Nevot7,
  11. A Núñez-Roldán1,
  12. J Martín2,*,
  13. M F González-Escribano1,*
  1. 1Servicio de Inmunología, Hospital Universitario Virgen del Rocío, Sevilla, Spain
  2. 2Instituto de Parasitología y Biomedicina “López Neyra”, Granada, Spain
  3. 3Servicio Reumatología, Hospital Xeral-Calde, Lugo, Spain
  4. 4Servicio Reumatología, Hospital La Paz, Madrid, Spain
  5. 5Servicio de Reumatología, Hospital Universitario Virgen del Rocío. Sevilla, Spain
  6. 6Servicio Inmunología, Hospital La Paz, Madrid, Spain
  7. 7Servicio Inmunología, Hospital Virgen de las Nieves, Granada, Spain
  1. Correspondence to:
    Dr M F González-Escribano
    Servicio de Inmunología, HU Virgen del Rocío, Avda Manuel Siurot s/n, 41013 Sevilla, Spain; mariaf.gonzalez.sspa{at}


Background: Asporin belongs to a family of proteins associated with the cartilage matrix.

Objective: To investigate the role of the functional polymorphism consisting of an aspartic acid (D) repeat polymorphism located in the ASPN gene in the susceptibility to and clinical outcome of rheumatoid arthritis.

Methods: A total of 803 Spanish Caucasian patients with rheumatoid arthritis and 904 controls of the same ethnic origin and matched for age and sex were included in the study. The asporin D repeat polymorphism was genotyped using polymerase chain reaction with a fluorescent primer.

Results: No significant differences were detected in the distribution of the 10 alleles found in our population on comparing patients with rheumatoid arthritis with control groups. Nevertheless, individuals bearing D14 produced rheumatoid factor more often than the rest (85.7% v 72.1%, p = 0.006, odds ratio (OR)  = 2.35, 95% confidence interval 1.21 to 4.50), and the mean (SD) onset age was higher in the group of individuals bearing D13 (50.09 (13.94)) compared with the rest (47.21 (14.31)), although the difference did not reach significance (p = 0.06).

Conclusion: The results do not support a major role for asporin D repeat polymorphism in the susceptibility to rheumatoid arthritis. Nevertheless, they support the influence of this gene on the outcome of the disease.

  • ASPN, asporin gene, PCR, polymerase chain reaction
  • TGF, transforming growth factor

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • * These authors contributed equally to this work.

  • Funding: This work was supported by grants Fondo de Investigaciones Sanitarias (PI 04–0067) and Plan Nacional de I+D+I (SAF03–3460) and Junta de Andalucía, grupos CTS-197 and CTS-180.

  • Competing interests: None declared.

  • Ethical approval and patient consent: All local ethical committees of the corresponding hospitals approved the study. Samples were obtained from subjects (patients and controls) after they had provided written informed consent.

  • Published Online First 17 May 2006